International Journal of Clinical Research

Objective: The purpose of this study is to improve the treatment level of anxiety combined with depression, and to apply escitalopram and venlafaxine separately in clinical practice to clarify their effects on patients with anxiety combined with depression. Method: A total of 95 patients with anxiety and depression who received diagnosis and treatment in the hospital during the period of January to December 2023 were selected as the analysis objects. After numbering each patient, a random selection method was used to set them as a control group (49 cases) and an observation group (46 cases). Two treatment interventions were implemented using the venlafaxine regimen and the escitalopram regimen, respectively, and the intervention situation was analyzed. In terms of related indicators, the observation group had higher values (P<0.05) compared to the control group. In terms of mental health status, the observation group had lower values in all aspects compared to the two groups (P<0.05). Conclusion: The application of escitalopram regimen in clinical practice is beneficial for improving related indicators such as serum serotonin, dopamine, and frequency and amplitude of EEG alpha waves, and promoting patients mental health.

Anxiety; Depression; Escitalopram; Venlafaxine